|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 15, 2017 ) The Europe Nucleic Acid Labelling Market was worth $359.27 million in 2016 and estimated to be growing at a CAGR of 8.25%, to reach $534.02 million by 2021. Nucleic Acid Labelling have many applications in fields of drug discovery and identification of new diseases.
Browse details of Europe Nucleic Acid Labelling Market Research Report @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/
Market Conditions:
Our genetic information is carried forward to next generation by nucleic acids which are large complex molecules. Two major types of them are DNA and RNA. They are labelled with tags which help in detection and purification. One of the labelling techniques is Random Priming. A marked counterpart is synthesized on denatured (single-stranded) DNA using short primers as the starting point. Due to the short strands to be synthesized, this system is very simple and fast. Labelling has numerous applications in drug discovery and disease identification.
Major factors accountable for the growth of market are increasing demand for personalized healthcare, increasing expenditure for health care, increasing funding for R&D in genomics and disease diagnosis. Yet, factors like expensive processing techniques and lack of skilled professionals are likely to confine the growth of market.
Avail Sample Market Brochure of the report for more information, Get a Copy @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/request-sample
Europe Nucleic Acid Labelling Market Segmentation:
• By Product: Introduction, Reagents and Kits [Labels (Radioactive Labels & Non-Radioactive Labels), Probes (Radioactive Probes & Non-Radioactive Probes)] and Services
• By Labelling Technique: Introduction, PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription and End Labelling
• By Application: Introduction, DNA Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization (FISH), Microarrays, Blotting, In-Situ Hybridization and Other Applications
• By End-Users: Introduction, Diagnostic Centres, Research Centres and Hospitals
• By Geography: Introduction, UK, Spain, Germany, Italy and France
Some of the prominent companies in Europe Nucleic Acid Labelling Market are:
• Thermo Fisher Scientific
• New England Biolabs
• PerkinElmer
• F.Hoffmann La-Roche AG
• General Electric Company
• Merck KGaA
• Enzo Biochem
• Promega Corporation
• Vector Laboratories
• Agilent Technologies
Inquiry before buying @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/inquire
Request for discount @ http://www.marketdataforecast.com/market-reports/europe-nucleic-acid-labelling-market-2933/request-discount
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact:
Abhishek Shukla
International Business Development Manager
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
